Innovative Israeli Med-Tech Providing Relief from Chronic Pain and PTSD
What It Is About
Syqe, a leading med-tech start-up based in Tel Aviv, has pioneered a game-changing solution for individuals suffering from chronic diseases, PTSD, and other ailments. The SyqeAir Inhaler is the first and only device authorized by Israel’s Defense Ministry and National Insurance Institute to provide this life-saving treatment free of charge.
Why It Matters
The SyqeAir Inhaler effectively delivers medical cannabis with precision, avoiding the common side effects of addiction and ensuring that patients receive pure, safe, and high-quality product. This breakthrough is not only significant due to its medical efficacy but also because it symbolizes Israel’s commitment to groundbreaking healthcare solutions for its citizens.
The Innovation
The SyqeAir Inhaler is a patient-first, portable and hand-held device that accurately regulates cannabis intake. This makes it possible to personalize treatments as per each patient’s medical prescriptions. The device comes with an app that tracks data for precise monitoring of patient status, improving treatment outcomes.
The Impact
According to Syqe, the inhaler offers quick relief from chronic neuropathic pain and helps improve sleep quality without significant psychoactive effects – a key advantage that enhances the quality of life for numerous patients.
Uplifting Veterans and Civilians
Especially beneficial is the impact on Israeli veterans and civilians. Post-traumatic stress sufferers, notably former IDF soldiers and security officers, now have access to this crucial treatment. The Nes totalling NIS 200 million ($54 million) allocated by Israel for medical cannabis primarily aids those who were injured during their service, reducing the economic and emotional burdens they face.
A Path to Safety and Research
The Syqe team has also conducted several clinical studies, substantiating the device’s efficacy and safety, with research results published in esteemed scientific journals. Syqe’s innovative technology aligns well with Israel’s dedication to advancing medical research and finding effective treatment options for chronic ailments.
Words from A Pioneer
Hagit Kamin, CEO of SyqeAir, emphasized their extraordinary commitment to providing the world’s medical standard for cannabis treatments, stressing its unique device features like regulated dosing and unmatched patient support. Dr. Eytan Hyam, Executive Medical Chairman, reiterates, “The medical community trusts cannabis, and we provide the technology that ensures its secure, efficacious administration.”
Testimonials Highlight Real Impact
IDF veteran Eyal Reinich recounts his transformative experience with SyqeAir due to its precise delivery and significant quality-of-life improvements. This veteran testimonial showcases how Israeli innovation directly transforms lives by addressing both physical and psychological pain effectively.
The Bigger Picture
As Syqe plans for global expansion, it signifies not just the impressive potential of Israeli-medical technology but also the global implications of reliability, responsiveness, and research-backed treatment methods originating from Israel.
Indeed, Syqe embodies its missionary commitment – it utilizes cutting-edge Israeli tech to significantly alleviate suffering across multiple spectrums, epitomizing a blend of innovation, compassion, and healthcare excellence.
This story was first published on jpost.com.